TCA
Trifecta Capital Advisors’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.24M | Buy |
39,028
+1,664
| +4% | +$309K | 1.21% | 29 |
|
|
2025
Q1 | $7.83M | Buy |
37,364
+907
| +2% | +$190K | 1.64% | 17 |
|
|
2024
Q4 | $6.48M | Buy |
36,457
+6,474
| +22% | +$1.15M | 1.28% | 24 |
|
|
2024
Q3 | $5.92M | Buy |
29,983
+148
| +0.5% | +$29.2K | 1.24% | 26 |
|
|
2024
Q2 | $5.12M | Buy |
29,835
+1,070
| +4% | +$184K | 1.13% | 27 |
|
|
2024
Q1 | $5.24M | Buy |
28,765
+26,480
| +1,159% | +$4.82M | 1.28% | 22 |
|
|
2023
Q4 | $354K | Sell |
2,285
-230
| -9% | -$35.6K | 0.1% | 71 |
|
|
2023
Q3 | $375K | Sell |
2,515
-29
| -1% | -$4.32K | 0.12% | 69 |
|
|
2023
Q2 | $343K | Hold |
2,544
| – | – | 0.11% | 70 |
|
|
2023
Q1 | $405K | Buy |
2,544
+29
| +1% | +$4.62K | 0.14% | 72 |
|
|
2022
Q4 | $406K | Buy |
+2,515
| New | +$406K | 0.16% | 71 |
|